Your browser doesn't support javascript.
loading
Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1.
García-Fumero, Ricardo; Fernández-López, Cristina; Calleja-Hernández, Miguel Ángel; Expósito-Hernández, José.
Affiliation
  • García-Fumero R; University of Granada, Granada, Spain.
  • Fernández-López C; University of Granada, Granada, Spain.
  • Calleja-Hernández MÁ; Department of Pharmacy, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Expósito-Hernández J; University of Granada, Granada, Spain.
Acta Oncol ; 60(9): 1225-1232, 2021 Sep.
Article in En | MEDLINE | ID: mdl-34184595
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Spain Country of publication: United kingdom